Goodwin Fk
About
In The Last Decade
Goodwin Fk
44 papers receiving 963 citations
Peers
Comparison fields: 5 of 89
- Psychiatry and Mental health 413
- Cellular and Molecular Neuroscience 311
- Pharmacology 244
- Molecular Biology 181
- Biological Psychiatry 138
Countries citing papers authored by Goodwin Fk
This map shows the geographic impact of Goodwin Fk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Goodwin Fk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Goodwin Fk more than expected).
Fields of papers citing papers by Goodwin Fk
This network shows the impact of papers produced by Goodwin Fk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Goodwin Fk. The network helps show where Goodwin Fk may publish in the future.
Co-authorship network of co-authors of Goodwin Fk
This figure shows the co-authorship network connecting the top 25 collaborators of Goodwin Fk. A scholar is included among the top collaborators of Goodwin Fk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Goodwin Fk. Goodwin Fk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Alcoholism research: delivering on the promise. | 2 |
| 2 | The biology of depression: conceptual issues. | 3 |
| 3 | Vasopressin function in depression and mania [proceedings]. | 17 |
| 4 | Methadone and morphine in depression [proceedings]. | 22 |
| 5 | Adrenocortical function and plasma norepinephrine in normal human subjects. | 15 |
| 6 | Cerebrospinal fluid amine metabolites and cyclic nucleotides in human aggression [proceedings]. | 39 |
| 7 | Brain-specific benzodiazepine receptors and putative endogenous "benzodiazepine-like" compounds. | 13 |
| 8 | Prediction of relapse in recurrent affective disorder. | 98 |
| 9 | The lithium ion -- impact on treatment and research: introduction. | 4 |
| 10 | CSF calcium: clinical correlates in affective illness and schizophrenia. | 91 |
| 11 | Dopamine-beta-hydroxylase in the cerebrospinal fluid of psychiatric patients. | 47 |
| 12 | Prediction of steady state plasma concentration of imipramine [proceedings]. | 5 |
| 13 | Calcium and electroconvulsive therapy of severe depressive illness. | 41 |
| 14 | Urinary excretion of 3-methoxy-4-hydroxyphenylglycol in depressed patients: modifications by amphetamine and lithium. | 11 |
| 15 | Clinical evidence for neurochemical adaptation to psychotropic drugs. | 11 |
| 16 | Cerebrospinal fluid amine metabolites in affective illness and schizophrenia: clinical and pharmacological studies. | 18 |
| 17 | Central dopamine function in affective illness: evidence from precursors, enzyme inhibitors, and studies of central dopamine turnover. | 13 |
| 18 | Assortative mating in the affective disorders. | 51 |
| 19 | Behavioral effects of l-dopa in man. | 24 |
| 20 | The compensation problem. | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.